Welcome to Medivizor!

You're browsing our sample library. Feel free to continue browsing. You can also sign up for free to receive medical information specific to your situation.

Posted by on Sep 14, 2018 in Lung cancer | 0 comments

In a nutshell

This study looked at the effect of vitamin D supplements at preventing relapse in non-small-cell lung cancer (NSCLC). The authors concluded that vitamin D supplements might have the potential for improving survival in patients with early-stage lung adenocarcinoma. 

Some background

Current therapy for early-stage NSCLC involves surgery followed by chemotherapy. Relapse rates are high, however. There is evidence that good vitamin D levels are associated with better survival in patients with early-stage NSCLC. While vitamin D is obtained naturally in the body from sunlight and diet, it can also be obtained by supplements. It is unclear if vitamin D supplements can improve outcomes for these patients.

Methods & findings

The trial included 144 patients with NSCLC. They were randomly assigned to be treated with vitamin D supplements (72 patients) or placebo (a substance with no effect on the body; 72 patients). The average follow-up period was 3.3 years. The authors examined relapse-free survival (RFS, time from beginning trial to relapse or death) and overall survival (OS, time from beginning trial until death). 

Overall, there was no difference in 5-year RFS and OS between both groups. 

However, patients with early-stage adenocarcinoma had a 77% better RFS and an 87% better OS when treated with vitamin D supplements compared to patients in the placebo group. 

The bottom line

The authors concluded that vitamin D supplements may improve survival of patients with early-stage adenocarcinoma with low vitamin D levels. 

The fine print

The number of patients in the trial was very low. Most of these patients were early stage and there is therefore very little information regarding late stage NSCLC. 

Published By :

Clinical Cancer Research

Date :

Jul 18, 2018

Original Title :

Vitamin D supplementation and survival of patients with non-small-cell lung cancer: A randomized, double-blind, placebo-controlled trial.

click here to get personalized updates